Role of Hydrogen Sulfide in Oral Disease.

Journal: Oxidative medicine and cellular longevity

Volume: 2022

Issue: 

Year of Publication: 2022

Affiliated Institutions:  School of Stomatology, Henan University, Kaifeng, Henan , China. Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng, Henan , China.

Abstract summary 

Oral diseases are among the most common human diseases yet less studied. These diseases affect both the physical, mental, and social health of the patients resulting in poor quality of life. They affect all ages, although severe stages are mostly observed in older individuals. Poor oral hygiene, genetics, and environmental factors contribute enormously to the development and progression of these diseases. Although there are available treatment options for these diseases, the recurrence of the diseases hinders their efficiency. Oral volatile sulfur compounds (VSCs) are highly produced in oral cavity as a result of bacteria activities. Together with bacteria components such as lipopolysaccharides, VSCs participate in the progression of oral diseases by regulating cellular activities and interfering with the immune response. Hydrogen sulfide (HS) is a gaseous neurotransmitter primarily produced endogenously and is involved in the regulation of cellular activities. The gas is also among the VSCs produced by oral bacteria. In numerous diseases, HS have been reported to have dual effects depending on the cell, concentration, and donor used. In oral diseases, high production and subsequent utilization of this gas have been reported. Also, this high production is associated with the progression of oral diseases. In this review, we will discuss the production of HS in oral cavity, its interaction with cellular activities, and most importantly its role in oral diseases.

Authors & Co-authors:  Wu Dong-Dong DD Ngowi Ebenezeri Erasto EE Zhai Yuan-Kun YK Wang Yi-Zhen YZ Khan Nazeer Hussain NH Kombo Ahmad Fadhil AF Khattak Saadullah S Li Tao T Ji Xin-Ying XY

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Scully C. Halitosis. BMJ Clinical Evidence . 2014;2014:p. 1305.
Authors :  9
Identifiers
Doi : 1886277
SSN : 1942-0994
Study Population
Male,Female
Mesh Terms
Apoptosis
Other Terms
Study Design
Study Approach
Country of Study
Publication Country
United States